630-580-1088 sales@ambeed.com
Structure Search

List Search MOL Search Structure Search

0
Chemistry
Asymmetric Synthesis >>Chiral Building BlocksChiral Catalysts, Chiral Ligands and Chiral ReagentsChiral Resolution ReagentsBoronic acids/esters >>Aliphatic BoronsAromatic BoronsOther BoronsOxaborolesCatalysis Chemistry >>Achiral Crown LigandsC-H ActivationCarbon-Donor LigandsChiral Carbon LigandsChiral Crown LigandsChiral Olefin LigandsCross-CouplingCross-Coupling Using Transition Metal CatalystsDACH or Trost LigandsChemical Biology >>Conjugation Chemistry
GlycoscienceLinkers and CrosslinkersNucleic Acid ChemistryPEGylationPeptide ChemistryPhotolabile Protecting GroupHeterocyclic Building Blocks >>AcridinesAliphatic HeterocyclesAromatic HeterocyclesAzetidinesBenzimidazolesBenzisoxazolesBenzodioxansBenzofuransBenzothiazolesInorganic reagents >>Inorganic reagentOrganic Building Blocks >>Acid AnhydridesAcyl Chlorides
AlcoholsAldehydesAliphatic Chain HydrocarbonsAliphatic Cyclic HydrocarbonsAlkenesAlkylsAlkynesOrganometallic Reagents >>Grignard ReagentsOrganoarsenicOrganobismuthOrganoboronOrganogermaniumOrganolithiumOrganomercuryOrganosiliconOrganotinSpecialty Synthesis >>Enzyme-Mediated SynthesisFluorous SynthesisIonic Liquids
Solid Supported SynthesisStains and Dyes >>Acid DyesAzoic DyesBasic DyesDirect DyesDisperse DyesDye IntermediatesMordant DyesOil DyesOther Stains and DyesSynthetic Reagents >>Acids and BasesC-C Bond FormationC-X Bond Formation (Halogen)C-X Bond Formation (Non-Halogen)Chelation and Complexation CompoundsCondensation AgentsCouplingDehydrating ReagentsFluorination Reagent
Pharmaceutical Intermediates
Analgesics >>BenzhydrocodoneBicifadineCapsaicinCelecoxibDebio-0827DexamethasoneElagolix SodiumEsketamine HydrochlorideIbuprofen sodiumAnesthetics >>CiprofolEsketamine HydrochlorideFospropofol Fospropofol DisodiumLevobupivacaine RemimazolamRemimazolam BesilateRemimazolam besylateRopivacaineAnti-Addiction Agents >>Kakonein
Lofexidine HydrochlorideVarenicline Anti-inflammatory Agents >>ApremilastAsunaprevirATB-346 RelatedBalsalazide BaricitinibBencycloquidium BromideBudesonideCefiderocol Sulfate TosylateCeftaroline Fosamil AcetateAntibacterials >>AFN-1252 RelatedAlatrofloxacin Bedaquiline FumarateBesifloxacin BrilacidinCaspofungin AcetateCefiderocol Sulfate TosylateCefilavancinCeftaroline Fosamil
Anticonvulsants >>BrivaracetamCannabidiolEscitalopram OxalateEslicarbazepine Acetate RelatedFosphenytoinGabapentin EnacarbilJNJ-10234094LacosamideLevetiracetam RelatedAntidementia Agents >>Azeliragon RelatedDavunetideDonepezil HydrochlorideDonepezil RelatedEnsaculinFlorbetaben Flortaucipir F 18Flutemetamol IdalopirdineAntidepressants >>4-Chlorokynurenine
AgomelatineAgomelatine RelatedAllopregnanolone RelatedAmibegronAmitifadineAripiprazole RelatedBasimglurantBefloxatoneAntiemetics >>AprepitantAprepitant RelatedDolasetron RelatedDolasetron Mesylate HydrateFosaprepitant DimeglumineFosaprepitant RelatedOlanzapinePalonosetron RelatedPalonosetron HydrochlorideAntifungals >>Anidulafungin RelatedCabotegravirMore >>
Inhibitors/Agonists
ADC >>ADC AntibodyADC LinkerADC Linker with PayloadADC ToxinAntibody-Drug Conjugates (ADCs)Drug-Linker Conjugates for ADCAngiogenesis >>ALKBcr-AblBTKEGFRFAKFGFRFLT3HER2HIFAnti-infection >>3CLproAntibacterialAntibioticAntifungal
AntiparasiticAntiprotozoalAntiviralArenavirusBVDVApoptosis >>Apoptosis InducerBcl-2Bcl-6BRKc-Mycc-RETC/EBPCARDCaspaseAutophagy >>Atg4ATG4BATTECsAUTACsAutophagyBeclin1
FKBPLC3LRRK2Biochemical Reagent >>Cell Cycle >>AntifolateAPCAurora KinaseBUBCasein KinaseCdc25CDKChkCRISPR/Cas9Cytoskeleton >>ActinArp2/3 ComplexCYTHCytoplasmic dyneinDynaminFAKMore >>
Material Science
Aggregation-Induced Emission >>Other AIE BlocksTetraphenylethylene SeriesCOFs Linkers >>Aldehyde COFs LinkersAlkynyl COFs LinkersAmine COFs LinkersBoric COFs LinkersCyano COFs LinkersMultifunctional COFs linkersOther COFs linkersTriphene seriesElectronic Materials >>Battery MaterialsDye-Sensitized Solar Cell (DSSC) MaterialsElectronic MaterialLiquid Crystal (LC) MaterialsMolecular ConductorsOrganic Light-Emitting Diode (OLED) MaterialsOrganic Solar Cell (OPV) MaterialsOrganic Transistor (OFET) MaterialsPerovskite Solar Cell (PSC) MaterialsMagnetic Materials >>Magnetic Ionic LiquidsMagnetic MaterialMagnetic Metal Complexes
Organic Radicals Material Chemical Compounds >>Ligands for Functional Metal ComplexesLiquid Crystal (LC) Building BlocksPhthalocyanine Building BlocksPolymer and Macromolecule Semiconductor Building BlocksSmall Molecule Semiconductor Building BlocksSolubility Enhancing Reagents Supramolecular Host Materials MOF Ligands >>Carboxylic Acid MOF LigandsCarboxylic Acid Nitrogen-Containing Mixed MOF LigandsNitrogen-Containing MOF LigandsOther MOF ligandsNanomaterials >>Carbon NanomaterialsCeramic MembranesDendrimersGold NanoparticlesIron Oxide NanoparticlesMaterials by ApplicationMesoporous MaterialsMetals and Metal AlloysNano Minerals: NanoclaysOLED Materials >>Dopant
HostHTMOLED IntermediatesOther OLED related materialsOptical Materials >>Coumarin DyesCyanine and Squarylium DyesDCM DyesDipyrromethene DyesFluorescence MaterialsFluorescent ProbesHeat and Pressure Sensitive DyesNear-Infrared (NIR) DyesOrganic Non-Linear Optical (NLO) MaterialsOrganic Pigments >>Organic PigmentOther Materials >>Mateial OtherPolymer Science >>MonomersPolymer AdditivesPolymerization ReagentsPolymersResins
Contact Us
Home Cart 0 Sign in  
Chemistry
Heterocyclic Building Blocks
Quinolines
Pelitinib
Chemistry
Inhibitors/Agonists
Heterocyclic Building Blocks
Enzyme Inhibitor Protein Tyrosine Kinase/RTK
Quinolines
Tyrosine / EGF Receptor Protein Kinase Inhibitor EGFR

[ CAS No. 257933-82-7 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
Chemical Structure| 257933-82-7
Chemical Structure| 257933-82-7
Structure of 257933-82-7 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Search after Editing

* Storage: {[proInfo.prStorage]}

For Research Only 110K+ Compounds Competitive Price 1-2 Day Shipping

Quality Control of [ 257933-82-7 ]

COA NMR CNMR HPLC LC-MS

Related Doc. of [ 257933-82-7 ]

SDS Specification
Alternatived Products of [ 257933-82-7 ]

Product Details of [ 257933-82-7 ]

CAS No. :257933-82-7 MDL No. :MFCD09837868
Formula : C24H23ClFN5O2 Boiling Point : -
Linear Structure Formula :- InChI Key :WVUNYSQLFKLYNI-AATRIKPKSA-N
M.W : 467.92 Pubchem ID :6445562
Synonyms :
EKB-569;WAY-EKB 569;WAY-172569

Calculated chemistry of [ 257933-82-7 ]

Physicochemical Properties

Num. heavy atoms : 33
Num. arom. heavy atoms : 16
Fraction Csp3 : 0.21
Num. rotatable bonds : 9
Num. H-bond acceptors : 6.0
Num. H-bond donors : 2.0
Molar Refractivity : 128.23
TPSA : 90.28 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : No
P-gp substrate : No
CYP1A2 inhibitor : No
CYP2C19 inhibitor : Yes
CYP2C9 inhibitor : Yes
CYP2D6 inhibitor : Yes
CYP3A4 inhibitor : Yes
Log Kp (skin permeation) : -5.93 cm/s

Lipophilicity

Log Po/w (iLOGP) : 3.74
Log Po/w (XLOGP3) : 4.54
Log Po/w (WLOGP) : 5.33
Log Po/w (MLOGP) : 2.34
Log Po/w (SILICOS-IT) : 4.57
Consensus Log Po/w : 4.1

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 0.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -5.37
Solubility : 0.00201 mg/ml ; 0.0000043 mol/l
Class : Moderately soluble
Log S (Ali) : -6.16
Solubility : 0.000325 mg/ml ; 0.000000695 mol/l
Class : Poorly soluble
Log S (SILICOS-IT) : -8.25
Solubility : 0.00000266 mg/ml ; 0.0000000057 mol/l
Class : Poorly soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 1.0 alert
Leadlikeness : 3.0
Synthetic accessibility : 3.44

Safety of [ 257933-82-7 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P280-P305+P351+P338 UN#:N/A
Hazard Statements:H302 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 257933-82-7 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 257933-82-7 ]
  • Downstream synthetic route of [ 257933-82-7 ]

[ 257933-82-7 ] Synthesis Path-Upstream   1~12

  • 1
  • [ 99083-25-7 ]
  • [ 124-40-3 ]
  • [ 361162-95-0 ]
  • [ 257933-82-7 ]
Reference： [1] Journal of Medicinal Chemistry, 2003, vol. 46, # 1, p. 49 - 63
  • 2
  • [ 106579-00-4 ]
  • [ 257933-82-7 ]
Reference： [1] Journal of Medicinal Chemistry, 2003, vol. 46, # 1, p. 49 - 63
[2] Journal of Medicinal Chemistry, 2003, vol. 46, # 1, p. 49 - 63
  • 3
  • [ 116435-75-7 ]
  • [ 257933-82-7 ]
Reference： [1] Journal of Medicinal Chemistry, 2003, vol. 46, # 1, p. 49 - 63
[2] Journal of Medicinal Chemistry, 2003, vol. 46, # 1, p. 49 - 63
  • 4
  • [ 361162-90-5 ]
  • [ 257933-82-7 ]
Reference： [1] Journal of Medicinal Chemistry, 2003, vol. 46, # 1, p. 49 - 63
[2] Journal of Medicinal Chemistry, 2003, vol. 46, # 1, p. 49 - 63
  • 5
  • [ 214476-07-0 ]
  • [ 257933-82-7 ]
Reference： [1] Journal of Medicinal Chemistry, 2003, vol. 46, # 1, p. 49 - 63
[2] Journal of Medicinal Chemistry, 2003, vol. 46, # 1, p. 49 - 63
  • 6
  • [ 361162-91-6 ]
  • [ 257933-82-7 ]
Reference： [1] Journal of Medicinal Chemistry, 2003, vol. 46, # 1, p. 49 - 63
[2] Journal of Medicinal Chemistry, 2003, vol. 46, # 1, p. 49 - 63
  • 7
  • [ 214476-09-2 ]
  • [ 257933-82-7 ]
Reference： [1] Journal of Medicinal Chemistry, 2003, vol. 46, # 1, p. 49 - 63
[2] Journal of Medicinal Chemistry, 2003, vol. 46, # 1, p. 49 - 63
  • 8
  • [ 214476-08-1 ]
  • [ 257933-82-7 ]
Reference： [1] Journal of Medicinal Chemistry, 2003, vol. 46, # 1, p. 49 - 63
[2] Journal of Medicinal Chemistry, 2003, vol. 46, # 1, p. 49 - 63
  • 9
  • [ 361162-92-7 ]
  • [ 257933-82-7 ]
Reference： [1] Journal of Medicinal Chemistry, 2003, vol. 46, # 1, p. 49 - 63
[2] Journal of Medicinal Chemistry, 2003, vol. 46, # 1, p. 49 - 63
  • 10
  • [ 492456-51-6 ]
  • [ 257933-82-7 ]
Reference： [1] Journal of Medicinal Chemistry, 2003, vol. 46, # 1, p. 49 - 63
[2] Journal of Medicinal Chemistry, 2003, vol. 46, # 1, p. 49 - 63
  • 11
  • [ 621-33-0 ]
  • [ 257933-82-7 ]
Reference： [1] Journal of Medicinal Chemistry, 2003, vol. 46, # 1, p. 49 - 63
[2] Journal of Medicinal Chemistry, 2003, vol. 46, # 1, p. 49 - 63
  • 12
  • [ 1056149-69-9 ]
  • [ 361162-95-0 ]
  • [ 257933-82-7 ]
Reference： [1] Journal of Medicinal Chemistry, 2003, vol. 46, # 1, p. 49 - 63

Tags: 257933-82-7 synthesis path| 257933-82-7 SDS| 257933-82-7 COA| 257933-82-7 purity| 257933-82-7 application| 257933-82-7 NMR| 257933-82-7 COA| 257933-82-7 structure

Same Skeleton Products
Related Products
Historical Records